Table 2. Designing a clinical trial in sickle cell disease.

Would you be willing to randomly assign young children to hydroxycarbamide or placebo in a trial?
Answer	Count	Percentage
No (A1)	4	7.69%
Yes, children	6	11.54%
Yes, children 6 months–2 years	23	44.23%
Yes, children 2–5 years (A4)	23	44.23%
Yes, children 5–10 years	21	40.38%
Yes, children older than 10 years	21	40.38%
Other	6	11.54%
Not completed or not displayed	10	19.23%